Protagonist Therapeutics, Inc — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d9fc8233-ba4f-484e-b286-69ce4f9aada3/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-130.1M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-050429 |
| FY 2024 | $275.2M | 2024-01-01 – 2024-12-31 | evidence 0001104659-26-050429 |
| FY 2023 | $-79.0M | 2023-01-01 – 2023-12-31 | evidence 0001104659-26-050429 |
| FY 2022 | $-127.4M | 2022-01-01 – 2022-12-31 | evidence 0001104659-26-050429 |
| FY 2021 | $-125.6M | 2021-01-01 – 2021-12-31 | evidence 0001104659-26-050429 |
| FY 2020 | $-66.2M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002715 |
| FY 2019 | $-77.2M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002334 |
| FY 2018 | $-38.9M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001853 |
| FY 2017 | $-37.0M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001637 |
| FY 2016 | $-37.2M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-073383 |
| FY 2015 | $-14.9M | 2015-01-01 – 2015-12-31 | evidence 0001193125-17-073383 |
| FY 2014 | $-11.1M | 2014-01-01 – 2014-12-31 | evidence 0001193125-17-073383 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Protagonist Therapeutics, Inc — all facts · Revenue · Operating Income